Price $3.27 |
Market Cap
81.5M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
22.7
|
P/B
-
|
P/S
1.57
|
Dividend %
-
|
|
P/CF
18.9
|
P/FCF
7.7
|
Op. Cash Flow
13.6K
|
FCF
0.4
|
|
Op. Margin
8.90%
|
Net Margin
10.10%
|
ROE
-7.30%
|
ROI
-31.90%
|
|
ROA
5.30%
|
EPS Growth
131.80%
|
Current Ratio
3.8
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Voyager Therapeutics Inc (VYGR) | $6.18 | - | - | 227.3M | Strong Buy |
| LogicMark Inc (LGMK) | $1.06 | - | - | 10.5M | Strong Buy |
| Lineage Cell Therapeutics Inc (LCTX) | $1.67 | - | - | 268.2M | Strong Buy |
| Lannett Company, Inc. (LCI) | $0.58 | - | - | 25M | Strong Buy |
| KORU Medical Systems Inc (KRMD) | $2.49 | - | - | 113.5M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
